Molecular Diagnostics Market to reach $10bn by 2023 - PowerPoint PPT Presentation

Loading...

PPT – Molecular Diagnostics Market to reach $10bn by 2023 PowerPoint presentation | free to download - id: 868da1-ZmUwY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Molecular Diagnostics Market to reach $10bn by 2023

Description:

Get more details @ Key industry players include Abbott Laboratories, Alere, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, Dako, bioMerieux, Cepheid, Hologic (Gen Probe), Danaher Corporation, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics, Johnson & Johnson, Qiagen, and Sysmex Corporation. – PowerPoint PPT presentation

Number of Views:11

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Molecular Diagnostics Market to reach $10bn by 2023


1
U.S. Molecular Diagnostics Market share to
surpass USD 4 billion by 2023Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Molecular Diagnostics Market
  • Global Molecular Diagnostics Market size is
    driven by increasing geriatric population and
    associated rise in chronic disease prevalence.
    According to UN estimates, population with more
    than 65 years of age should witness substantial
    increase from 901 million in 2015 to 2.1 billion
    by 2050.
  • Emergence of technologically advanced diagnostic
    products should offer promising market growth
    opportunities for industry players. Furthermore,
    growing demand for point of care diagnostics
    (PoC) will accelerate molecular diagnostics
    market growth.
  • Growing adoption of personalized medicines and
    companion diagnostics, improved acceptance of
    diagnostic devices by healthcare practitioners,
    and increasing research funding to conduct
    medical diagnostics clinical studies, should
    propel growth.
  • HPV is anticipated to expand at impressive 9.8
    CAGR from 2016 to 2023. Growing HPV prevalence
    should provide lucrative market expansion
    opportunities to industry participants. As per
    CDC, around 79 million people are infected with
    HPV in the U.S. alone.

3
Continued...
  • PCR held more than 45 of molecular diagnostics
    market share in 2016. Emergence of new
    technologies such as genetic sequencing and
    in-situ hybridization should hinder growth over
    the forecast period.
  • U.S. molecular diagnostics market size should
    surpass USD 4 billion by 2023 owing to improved
    healthcare infrastructure, high technology
    adoption and increased patient awareness
    regarding early disease diagnosis.
  • India molecular diagnostics market size should
    manifest robust growth attributed to huge patient
    numbers suffering from infectious diseases,
    effective preventive healthcare policies, rapid
    economic development and improvement in
    healthcare infrastructure throughout the country.
  • Key industry participants include Alere, Abbott
    Laboratories, Becton Dickinson, Bayer Healthcare,
    Bio-Rad Laboratories, bioMerieux, Cepheid, Dako,
    Hologic (Gen Probe), Danaher Corporation, Johnson
    Johnson, Qiagen, Novartis (Grifols), Siemens
    Healthcare, Roche Diagnostics and Sysmex.

4
Germany Molecular diagnostics market size, by
technology, 2012-2023 (USD Million)

5

Browse Full Market Research Report On Molecular
Diagnostics Market _at_ http//bit.ly/2oUDIou
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/434
6
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com